Kiyoshi Seki, Hiroshi Suzuki, Seiji Abe, Chikako Saotome. Lifecycle management of orphan drugs approved in Japan. Orphanet Journal of Rare Diseases. 2022. 17. 1
早乙女 周子. バイオベンチャーの事業における特許出願の重要性. LES Japan News,. 2017. 58. 46-54
Chikako Saotome, Yurie Nakaya, Seiji Abe. Patent production is a prerequisite for successful exit of a biopharmaceutical company. DRUG DISCOVERY TODAY. 2016. 21. 3. 406-409